U.S., Dec. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07276724) titled 'A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)' on Dec. 01.
Brief Summary: The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma that is uncontrolled by inhaled corticosteroids (ICS) and conventional asthma controllers.
The study details include:
Study treatment: randomized to receive either GB-0895 or placebo administered every 6 months over 52 weeks.
Visit frequency: every 1-2 months after the first month.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Co...